BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 2.11.2018

Product Development in Hemophilia; Public Workshop

The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public workshop entitled "Product Development in Hemophilia." The purpose of the public workshop is to discuss issues related to development and regulation of novel hemophilia products.

Source: Federal Register — Food and Drug AdministrationOpen original release →